MARKET

LFCR

LFCR

Lifecore Biomedical Inc
NASDAQ
4.660
-0.350
-6.99%
Closed 19:42 08/10 EDT
OPEN
4.980
PREV CLOSE
5.01
HIGH
5.00
LOW
4.660
VOLUME
100.23K
TURNOVER
0
52 WEEK HIGH
8.98
52 WEEK LOW
3.625
MARKET CAP
176.40M
P/E (TTM)
-4.0892
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LFCR last week (0803-0807)?
Weekly Report · 22h ago
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Elanco Animal Health (ELAN) and Alpha Teknova (TKNO)
TipRanks · 4d ago
Analysts Are Bullish on Top Healthcare Stocks: Palvella Therapeutics (PVLA), Lifecore Biomedical (LFCR)
TipRanks · 5d ago
Lifecore reports Q2 EPS (19c), consensus (22c)
TipRanks · 5d ago
Lifecore backs FY26 revenue view $120M-$125M, consensus $122.18M
TipRanks · 5d ago
*Lifecore Biomedical Backs 2026 Adj EBITDA of $20.5M-$25M >LFCR
Dow Jones · 5d ago
*Lifecore Biomedical Backs 2026 Rev $120M-$125M >LFCR
Dow Jones · 5d ago
*Lifecore Biomedical 2Q Adjusted EBITDA $8.6M >LFCR
Dow Jones · 5d ago
More
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization that provides services in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes, vials and cartridges. It manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. It manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. It also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.

Webull offers Lifecore Biomedical Inc stock information, including NASDAQ: LFCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFCR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LFCR stock methods without spending real money on the virtual paper trading platform.